Jesy Nelson has expressed the urgency of her twins’ Spinal Muscular Atrophy (SMA) diagnosis, highlighting the critical nature of the situation. She emphasized her frustration at the lack of attention to the condition until her personal experience brought it to light.

The Little Mix star, who shared the emotional news of her daughters’ diagnosis in a recent video, met with Health Secretary Wes Streeting to advocate for newborn screening for SMA, the disease affecting her children. Medical professionals have informed Jesy that her daughters may never be able to walk.

In an interview with Sky News’ The UK Tonight program hosted by Sarah-Jane Mee, Jesy, who became a mother in May last year, expressed her disappointment that it took her situation for the issue to be taken seriously. She highlighted the gravity of the situation, stressing that it is a matter of life and death for children. Jesy questioned the authority that decides the fate of children affected by SMA despite advancements in treatments over the years.

During an appearance on This Morning, Jesy fought back tears as she recounted noticing early signs of the condition in her twin babies, realizing they might face mobility challenges in the future. She shared her initial concerns about their leg movements and the delayed recognition of the issue by healthcare professionals visiting her home.

Jesy admitted that her mother’s observation of her babies’ limited leg movements played a crucial role in prompting further investigation. She acknowledged the emotional toll of the situation, constantly reflecting on what might have happened if the issue had gone unnoticed.

The Mirror is actively campaigning for the inclusion of a simple £5 SMA check in the NHS newborn heel prick test, aiming to detect and treat the condition early to prevent irreversible nerve damage. Many developed countries already conduct SMA screenings at birth to mitigate the impact of the disease.

Jesy’s advocacy efforts and personal story have shed light on the importance of early detection and treatment for SMA, emphasizing the need for proactive measures to safeguard children’s health.

Please note that this content may be subject to data collection through cookies and other identifiers as outlined in the site’s Privacy Notice and Terms and Conditions.